2nd Quarter - Report
BEONE MEDICINES USA, INC. (FORMERLY BEIGENE USA, INC.) for BEONE MEDICINES USA, INC (FORMERLY BEIGENE USA, INC.)
Income
—
Expenses
$220,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug pricing; Issues related to the drug approval and review process; issues related to operations of the Department of Veterans Affairs including work with clinical trials and research studies; implementation of the Inflation Reduction Act; ORPHAN Cures Act and pharmacy benefit manager legislation; ORPHAN Cures Act language in H.R. 1, One Big Beautiful Bill Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN PAUL HALLIWELL | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| BEONE MEDICINES LTD. (FORMERLY BEIGENE, LTD.) | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.